Literature DB >> 12667677

Basiliximab interferes with the detection of soluble IL-2 receptor by the Immulite Immunoassay system.

Michiel C Warlé1, Jaap Kwekkeboom, Hugo W Tilanus, Herold J Metselaar.   

Abstract

The use of the Immulite Automated Immunoassay system is becoming an increasingly popular method for accurate and fast measurement of sIL-2R in serum. Here, we report that detection of sIL-2R using the Immulite Immunoassay system in serum samples of patients who are treated with basiliximab, a monoclonal antibody against the alpha-chain of the IL-2 receptor, may lead to false measurements.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667677     DOI: 10.1016/s0022-1759(03)00016-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  1 in total

1.  Case of a patient with progressive adult T-cell leukemia/lymphoma treated successfully by reduced-intensity conditioning stem cell transplantation from an HLA-incompatible related donor.

Authors:  Hiroshi Fujiwara; Hideaki Kawada; Kakushi Matsushita; Heiichiro Hamada; Atsuo Ozaki; Hirosaka Inoue; Makoto Yoshimitsu; Toshimasa Kukita; Kosei Arimura; Hideo Ohtsubo; Kimiharu Uozumi; Naomichi Arima; Chuwa Tei
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.